SCHEMBL890366

SCHEMBL890366

COc1ccc2cc(CCCc3cc(C)ccc3S(=O)(=O)O)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.50
SLC2A1 P11166 3/20 0.48
KDM4E B2RXH2 1/20 0.47
NPC1 O15118 1/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
MAOA P21397 1/20 0.47
SLC6A2 P23975 1/20 0.47
RAB9A P51151 1/20 0.47
SLC6A3 Q01959 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ESR1 P03372 1/20 0.43
CYP19A1 P11511 1/20 0.43
ESR2 Q92731 1/20 0.43
PTGS1 P23219 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9367114 0.86 IGF1R (0.46) LMNASMN1; SMN2ESR1CYP19A1ESR2
SCHEMBL18917599 0.83 IGF1R (0.40) NPC1RAB9ASMN1; SMN2ESR1CYP19A1
SCHEMBL10372347 0.82 CALM1 (0.47) LMNAMAPTRAB9ASMN1; SMN2CALM1
SCHEMBL7028563 0.82 IGF1R (0.42) KDM4ENPC1CYP1A2CYP3A4MAPT
SCHEMBL5679284 0.81 IDH1 (0.44) LMNASMN1; SMN2ALDH1A1
SCHEMBL7025423 0.81 CTDSP1 (0.45) LMNACYP1A2MAPTSMN1; SMN2ALDH1A1
SCHEMBL30723203 0.80 GAA (0.39) KDM4ELMNACYP3A4MAPTESR2
SCHEMBL816601 0.80 GAA (0.39) KDM4ELMNACYP3A4MAPTESR2
SCHEMBL18917603 0.79 TDP1 (0.40) NPC1RAB9ASMN1; SMN2CYP19A1AKR1C3
SCHEMBL5950230 0.79 CHRM2 (0.47) MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2860169-B1 Method for obtaining novel derivatives of naphtalene for the in vivo diagnosis of Alzheimer's disease CENTRO DE NEUROCIENCIAS DE CUBA (CU) 2018-08-29 EP disclosed
EP-2860169-A2 Method for obtaining novel derivatives of naphtalene for the in vivo diagnosis of Alzheimer's disease Centro De Neurociencias De Cuba (CU) 2015-04-15 EP disclosed
EP-2436666-A2 METHOD FOR OBTAINING NOVEL DERIVATIVES OF NAPHTALENE FOR THE IN VIVO DIAGNOSIS OF ALZHEIMER 'S DISEASE Centro De Neurociencias De Cuba (CU) 2012-04-04 EP disclosed